CEO, UVA HEALTH; INTERIM EXECUTIVE VICE PRESIDENT FOR HEALTH AFFAIRS, UNIVERSITY OF VIRGINIA, CHARLOTTESVILLE
Virginia Business //September 1, 2025//
CEO, UVA HEALTH; INTERIM EXECUTIVE VICE PRESIDENT FOR HEALTH AFFAIRS, UNIVERSITY OF VIRGINIA, CHARLOTTESVILLE
Virginia Business //September 1, 2025//
UPDATED SEPT. 12, 2025
A nephrologist who joined the University of Virginia’s medical school as a professor in 2005, Rosner was named CEO of the health system as well as executive vice president for health affairs for the University of Virginia on Sept. 12 after serving as the health system’s interim leader for seven months.
In his role, Rosner oversees UVA Health, which includes four hospitals across Charlottesville, Culpeper and Northern Virginia, along with the UVA School of Medicine, UVA School of Nursing, UVA Physicians Group and the Claude Moore Health Sciences Library.
His predecessor, Dr. K. Craig Kent, resigned in February following an investigation into allegations in a “no confidence” letter signed by 128 physicians in 2024.
Rosner has dealt with multiple challenges in recent months, including sparring between former and current health system board officials and medical school faculty members, as well as the departures of Dr. Melina Kibbe, the medical school’s dean, and the CEO of the U.Va. Medical Center.
Meanwhile, though, the university is building the $350 million Paul and Diane Manning Institute of Biotechnology, working to develop cures for cancer and neurodegenerative diseases. The institute’s 350,000-square-foot facility is under construction, with completion expected in 2027.
ADVICE FOR NEW COLLEGE GRADS: Be open to new experiences, embrace change, build strong relationships and continuously learn.
MOST VALUED POSSESSION: 1969 New York Mets baseball card set
t